15307-86-5
基本信息
奥尔芬
2-[(2,6-二氯苯基)氨基]-苯乙酸
(N-1-(2,6-DICHLOROPHENYL) -2-INDOLIN-2-ONE
Diciofenac
2-[[2,6-Dichlorophenyl] amino] benzeneacetic acid
1-(2,6-DICHLOROPHENYL)-2-INDOLINONE /MEQUITAZINE
1-(2,6-DICHLOROPHENYL)-2-INDOLINONE/INDOLINONE
DICLOFENAC ACID/[2-(2,6-DICHLORO-PHENYLAMINO)-PHENY]-ACETIC ACID
(o-(2,6-dichloroanilino)phenyl)-acetic acid
dichlofenac
[2-(2,6-Dichloroanilino)phenyl]-acetic acid
2-[2-(2,6-Dichlorophenyl)aminophenyl]ethanoic acid
Diclofenac
DICLOFENAC FREE ACID
Rhumalgan
2-(2-(2,6-dichlorophenylamino)phenyl)acetic acid
物理化学性质
熔点 | 156-158° |
沸点 | 412.0±45.0 °C(Predicted) |
密度 | 1.431±0.06 g/cm3(Predicted) |
储存条件 | Sealed in dry,Room Temperature |
溶解度 | 溶于甲醇 |
酸度系数(pKa) | pKa 4 (Uncertain) |
形态 | 粉末晶体 |
颜色 | 白色到近乎白色 |
水溶解性 | 1.278mg/L(30 ºC) |
Merck | 14,3081 |
InChIKey | DCOPUUMXTXDBNB-UHFFFAOYSA-N |
CAS 数据库 | 15307-86-5(CAS DataBase Reference) |
NIST化学物质信息 | Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-(15307-86-5) |
EPA化学物质信息 | Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]- (15307-86-5) |
安全数据
危险性符号(GHS) | GHS06,GHS08,GHS09 |
警示词 | 危险 |
危险性描述 | H301-H361d-H372-H411 |
防范说明 | P202-P260-P264-P270-P273-P301+P310 |
危险品运输编号 | 3249 |
RTECS号 | AG6310000 |
海关编码 | 2922.49.2600 |
危险等级 | 6.1(b) |
包装类别 | III |
毒害物质数据 | 15307-86-5(Hazardous Substances Data) |
应用领域
常见问题列表
双氯芬酸的作用机理为抑制环氧化酶活性,从而阻断花生四烯酸向前列腺素的转化生成,因前列腺素为引起疼痛、发烧及发炎等之现象的主要因子。
Human COX-2 1.3 nM (IC 50 , in CHO cells) |
Human COX-1 4 nM (IC 50 , in CHO cells) |
Ovine COX-2 0.84 μM (IC 50 ) |
Ovine COX-1 5.1 μM (IC 50 ) |
Diclofenac effectively blocks COX-1 mediated prostanoid production from U937 cell microsomes, with an IC
50
of 7±3 nM.
Diclofenac (1-60 μM; 1 day) induces neural stem cells (NSCs)death in a concentration-dependent manner.
Diclofenac (10-60 μM; 6 hours) increases the expression of cleaved (activated) caspase-3.
Cell Viability Assay
Cell Line: | Neural stem cells (NSCs) |
Concentration: | 1, 3, 10, 30, 60 μM |
Incubation Time: | 1 day |
Result: | Induction of cell death was concentration-dependent and the effect was not saturated at a concentration of up to 60 μM. |
Western Blot Analysis
Cell Line: | Neural stem cells (NSCs) |
Concentration: | 10, 30 or 60 μM |
Incubation Time: | 6 hours |
Result: | The activation of caspase-3 was increased in a concentration-dependent manner. |
Diclofenac (3 mg/kg, b.i.d., for 5 days) significantly increases faecal
51
Cr excretion in rats, and such effect is also observed in squirrel monkeys after administrated of 1 mg/kg twice daily for 4 days.
Diclofenac (10 mg/kg; administered via oral route just prior to induction of inflammation) shows in vivo anti-inflammatory activity in Wistar rats.
Animal Model: | Male Sprague-Dawley rats (150±200 g) |
Dosage: | 3 mg/kg |
Administration: | Oral administration, b.i.d., for 5 days |
Result: | Resulted in a significant increase in faecal 51 Cr excretion. |
Animal Model: | Wistar rats (150-175 g) bearing Formalin-induced rat foot paw edema model |
Dosage: | 10 mg/kg |
Administration: | Administered via oral route just prior to induction of inflammation |
Result: | Showed in vivo anti-inflammatory activity (% edema inhibition=29.2, 1 h; 22.2, 3 h; 20, 6 h). |
双氯芬酸价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2024/11/11 | XW153078652 | 双氯芬酸 | 15307-86-5 | 5G | 49元 |
2024/11/08 | HY-15036 | 双氯芬酸 Diclofenac | 15307-86-5 | 500mg | 350元 |
2024/11/08 | HY-15036 | 双氯芬酸 Diclofenac | 15307-86-5 | 5G | 484元 |